BioNTech competitorsClear all

BioNTech's top competitors include Kite Pharma, 3sbio, Evotec and Oncternal Therapeutics.
BioNTech
BioNTech
BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Kite Pharma
Kite Pharma
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications.
3sbio
3sbio
3sbio (三生制药集团) is a company that develops biopharmaceuticals.
Evotec
Evotec
Evotec is a drug discovery alliance and development partnership company.
Oncternal Therapeutics
Oncternal Therapeutics
Oncternal Therapeutics is a clinical-stage oncology company developing first-in-class and novel therapies for both rare and common cancers.
Founding Date
Founding Date
2008
Founding Date
2009
Founding Date
1993
Founding Date
1993
Founding Date
2013
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Mainz, DE HQ
Halle (Saale), DE
Idar Oberstein, DE
Marburg, DE
Neuried, DE
Planegg, DE
Cambridge, US
see more
Locations
Santa Monica, US HQ
Amsterdam, NL
Hoofddorp, NL
Hayes, GB
Hayes, GB
El Segundo, US
Emeryville, US
see more
Locations
George Town, KY HQ
Locations
Hamburg, DE HQ
Orth An Der Donau, AT
Lyon, FR
Toulouse, FR
Göttingen, DE
Köln, DE
Planegg, DE
see more
Locations
San Diego, US HQ
Employees
Employees
1,30018% increase
Employees
2,5471% increase
Employees
5,437
Employees
3,2784% increase
Employees
N/A
Valuation ($)
Valuation ($)
25.6 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
6 b
Valuation ($)
N/A
Twitter followers
Twitter followers
36.9 k
Twitter followers
3.8 k
Twitter followers
N/A
Twitter followers
2.5 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
21
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
659
Average likes per tweet (last 30 days)
8.6
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3.1
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
258022
Alexa Website Rank
286065
Alexa Website Rank
N/A
Alexa Website Rank
305756
Alexa Website Rank
448501
Employee Rating
Employee Rating
3.6
Employee Rating
3.6
Employee Rating
3
Employee Rating
2.9
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
€2m (FY, 2019)
Revenue (est.)
$22.2m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
€446.4m (FY, 2019)
Revenue (est.)
N/A
Cost of goods
Cost of goods
€17.4m (FY, 2019)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
€313.5m (FY, 2019)
Cost of goods
N/A
Gross profit
Gross profit
(€15.4m) (FY, 2019)
Gross profit
N/A
Gross profit
N/A
Gross profit
€132.9m (FY, 2019)
Gross profit
N/A
Net income
Net income
(€179.2m) (FY, 2019)
Net income
($267.1m) (FY, 2016)
Net income
N/A
Net income
€37.2m (FY, 2019)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 1.4b
Total funding raised
$ 85.3m
Total funding raised
$ 15.2m
Total funding raised
$ 455m
Total funding raised
$ 18.6m
For sources of this data, please see the company profile

View company profiles

Kite Pharma
HQ
Santa Monica, US

Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications.

View company
3sbio
HQ
George Town, KY
Employees
5,437

3sbio (三生制药集团) is a company that develops biopharmaceuticals.

View company
Evotec
HQ
Hamburg, DE
Employees
3,278↑ 4% increase

Evotec is a drug discovery alliance and development partnership company.

View company
Oncternal Therapeutics
HQ
San Diego, US

Oncternal Therapeutics is a clinical-stage oncology company developing first-in-class and novel therapies for both rare and common cancers.

View company